Tag: entrepreneurs
-
Protein Made by Synthetic Bacteria with Expanded DNA
An academic-industry lab team produced a synthetic protein from an engineered bacteria, with DNA modified to expand its number of chemical coding components.
-
Survey: More Research Patents, Start-Ups in 2016
A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016.
-
Process Devised for Continuous Stem Cell Production
Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies.
-
Biotech Licenses Mayo Clinic Microbiome Research
A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases.
-
Plasma Infusions to Treat Alzheimer’s Shown Safe
Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities.
-
Start-Up Formed to Develop Non-Opioid Pain Drugs
A new enterprise is being formed to develop non-addictive drugs for chronic pain that use different biochemical processes than opioid pain relievers.
-
Can You Set Up Shop In An Industry You Know Nothing About?
More often than not, you can learn all you need to know about any line of business.
-
Multi-Drug Resistance Antibiotic Developer to Issue IPO
A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering.
-
Big Data Analysis Platform for Brainwaves in Development
Two companies in Northern Ireland, U.K. are creating a technology platform applying big data analytics to a collection of brainwaves generated by mobile games for measuring cognitive health.
-
Univ. Lab, Company Broaden Bacterial Vaccine Impact
Researchers from University at Buffalo and a campus spin-off enterprise devised a way to expand the scope of anti-bacterial vaccines, as shown in tests with lab animals.